257 related articles for article (PubMed ID: 29518640)
1. The prevalence of occult endometrial cancer in women undergoing hysterectomy for benign indications.
Parsons LHP; Pedersen R; Richardson DL; Kho KA
Eur J Obstet Gynecol Reprod Biol; 2018 Apr; 223():108-112. PubMed ID: 29518640
[TBL] [Abstract][Full Text] [Related]
2. Prevalence, characteristics, and risk factors of occult uterine cancer in presumed benign hysterectomy.
Desai VB; Wright JD; Gross CP; Lin H; Boscoe FP; Hutchison LM; Schwartz PE; Xu X
Am J Obstet Gynecol; 2019 Jul; 221(1):39.e1-39.e14. PubMed ID: 30853364
[TBL] [Abstract][Full Text] [Related]
3. Incidence of Occult Uterine Malignancy Following Vaginal Hysterectomy With Morcellation.
Wasson M; Magtibay P; Magtibay P; Magrina J
J Minim Invasive Gynecol; 2017; 24(4):665-669. PubMed ID: 28254678
[TBL] [Abstract][Full Text] [Related]
4. Risk of Occult Uterine Sarcoma in Women Undergoing Hysterectomy for Benign Indications.
Kho KA; Lin K; Hechanova M; Richardson DL
Obstet Gynecol; 2016 Mar; 127(3):468-473. PubMed ID: 26855091
[TBL] [Abstract][Full Text] [Related]
5. The prognostic and therapeutic implications of cytologic atypia in patients with endometrial hyperplasia.
Hunter JE; Tritz DE; Howell MG; DePriest PD; Gallion HH; Andrews SJ; Buckley SB; Kryscio RJ; van Nagell JR
Gynecol Oncol; 1994 Oct; 55(1):66-71. PubMed ID: 7959270
[TBL] [Abstract][Full Text] [Related]
6. Risk of incidental finding of endometrial cancer at the time of hysterectomy for benign condition.
Ouldamer L; Rossard L; Arbion F; Marret H; Body G
J Minim Invasive Gynecol; 2014; 21(1):131-5. PubMed ID: 23962573
[TBL] [Abstract][Full Text] [Related]
7. The incidence of unexpected gynaecological malignancies in hysterectomies carried out for benign indications.
Yildiz G; Mat E; Yildiz P; Gundogdu EC; Basol G; Kurt D; Kale A
J Obstet Gynaecol; 2021 Feb; 41(2):298-304. PubMed ID: 33448228
[TBL] [Abstract][Full Text] [Related]
8. Does persistent postmenopausal bleeding justify hysterectomy?
Fung Kee Fung M; Burnett M; Faught W
Eur J Gynaecol Oncol; 1997; 18(1):26-8. PubMed ID: 9061317
[TBL] [Abstract][Full Text] [Related]
9. Incidence of occult malignancies identified during hysterectomies performed for benign indications.
Topdagi Yilmaz EP; Cimilli Senocak GN; Topdagi YE; Aynaoglu Yildiz G; Kumtepe Y
J Gynecol Obstet Hum Reprod; 2020 Mar; 49(3):101620. PubMed ID: 31449888
[TBL] [Abstract][Full Text] [Related]
10. Body mass index trumps age in decision for endometrial biopsy: cohort study of symptomatic premenopausal women.
Wise MR; Gill P; Lensen S; Thompson JM; Farquhar CM
Am J Obstet Gynecol; 2016 Nov; 215(5):598.e1-598.e8. PubMed ID: 27287687
[TBL] [Abstract][Full Text] [Related]
11. Endometrial pathology in postmenopausal women with no bleeding.
Genc M; Genc B; Sahin N; Celik E; Turan GA; Gur EB; Guclu S
Climacteric; 2015 Apr; 18(2):241-5. PubMed ID: 25017611
[TBL] [Abstract][Full Text] [Related]
12. Risk for advanced-stage endometrial cancer in surgical specimens from patients with complex endometrial hyperplasia with atypia.
Eddib A; Allaf B; Lee J; Yeh J
Gynecol Obstet Invest; 2012; 73(1):38-42. PubMed ID: 22056948
[TBL] [Abstract][Full Text] [Related]
13. Occult endometrial cancer in women undergoing hysterectomy for benign indications: a retrospective cohort study in a tertiary hospital in China.
Cao Y; Shi H; Zhuo X
Arch Gynecol Obstet; 2024 May; ():. PubMed ID: 38727815
[TBL] [Abstract][Full Text] [Related]
14. The incidence of unexpected uterine malignancies in hysterectomies carried out for benign indications.
Ding Y; Han Y; Zhang S; Shi X
J Cancer Res Clin Oncol; 2023 Jul; 149(8):4339-4345. PubMed ID: 36083311
[TBL] [Abstract][Full Text] [Related]
15. Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study.
Trimble CL; Kauderer J; Zaino R; Silverberg S; Lim PC; Burke JJ; Alberts D; Curtin J
Cancer; 2006 Feb; 106(4):812-9. PubMed ID: 16400639
[TBL] [Abstract][Full Text] [Related]
16. Unexpected gynecologic malignancy diagnosed after hysterectomy performed for benign indications.
Mahnert N; Morgan D; Campbell D; Johnston C; As-Sanie S
Obstet Gynecol; 2015 Feb; 125(2):397-405. PubMed ID: 25569001
[TBL] [Abstract][Full Text] [Related]
17. Histopathologic correlation of dilatation and currettage and hysterectomy specimens in patients with postmenopausal bleeding.
Saygili H
Eur J Gynaecol Oncol; 2006; 27(2):182-4. PubMed ID: 16620067
[TBL] [Abstract][Full Text] [Related]
18. Incidence of sarcoma in patients undergoing hysterectomy for benign indications: a population-based study.
Multinu F; Casarin J; Tortorella L; Huang Y; Weaver A; Angioni S; Melis GB; Mariani A; Stewart EA; Laughlin-Tommaso SK
Am J Obstet Gynecol; 2019 Feb; 220(2):179.e1-179.e10. PubMed ID: 30447212
[TBL] [Abstract][Full Text] [Related]
19. Histopathologic assessment of the entire endometrium in asymptomatic women.
Mingels MJ; Geels YP; Pijnenborg JM; van der Wurff AA; van Tilborg AA; van Ham MA; Massuger LF; Bulten J
Hum Pathol; 2013 Oct; 44(10):2293-301. PubMed ID: 23938162
[TBL] [Abstract][Full Text] [Related]
20. Concurrent endometrial carcinoma following hysterectomy for atypical endometrial hyperplasia.
Hahn HS; Chun YK; Kwon YI; Kim TJ; Lee KH; Shim JU; Mok JE; Lim KT
Eur J Obstet Gynecol Reprod Biol; 2010 May; 150(1):80-3. PubMed ID: 20185225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
